The difficult lives of individuals with bipolar disorder: A review of functional outcomes and their implications for treatment

Journal of Affective Disorders

Volumn 209, Issue , 2017, Pages 147-154

  Gitlin, Michael J ^a   Miklowitz, David J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cognitive remediation; Depression; Mania; Mood stabilizers; Neurocognition; Stimulants

Indexed keywords

BIPOLAR DISORDER; COGNITION; COGNITIVE DEFECT; COGNITIVE THERAPY; COMORBIDITY; CROSS-SECTIONAL STUDY; DEPRESSION; DRUG DEPENDENCE; FUNCTIONAL DISEASE; HUMAN; HYPOMANIA; LONGITUDINAL STUDY; MANIA; MENTAL STRESS; OUTCOME ASSESSMENT; PERSONALITY; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW; AFFECT; DAILY LIFE ACTIVITY; PSYCHOLOGY; QUALITY OF LIFE;

ACTIVITIES OF DAILY LIVING; AFFECT; BIPOLAR DISORDER; COGNITION; DEPRESSION; HUMANS; QUALITY OF LIFE;

EID: 85000419787     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2016.11.021     Document Type: Review

References (102)

1. Altshuler, L.L., Gitlin, M.J., Mintz, J., et al. Subsyndromal depression in associated with functional impairment in patients with bipolar disorder. J. Clin. Psychiatry 63 (2002), 807–811.
2. Altshuler, L.L., Post, Rm, Black, D.O., et al. Subsyndromal depressive symptoms are associated with functional impairment in patients with bipolar disorder: results of a large, multisite study. J. Clin. Psychiatry 67 (2006), 1551–1560.
3. Anaya, C., Martinez-Aran, A., Ayuso-Mateos, J.L., et al. A systematic review of cognitive remediation for schizo-affective and affective disorders. J. Affect Disord. 142 (2012), 13–21.
4. Andreou, C., Bozikas, The predictive significance of neurocognitive factors for functional outcome in bipolar disorder. Curr. Opin. Psychiatry 26 (2013), 54–59.
5. Baldessarini, R.J., Salvatore, P., Khalsa, H.M., Gebre-Medhin, P., et al. Morbidity in 303 first-episode bipolar I disorder patients. Bipolar Disord., 12, 2010 (264-27).
6. Bauer, M.S., Kirk, G.F., Gavin, C., et al. Determinants of outcome and healthcare costs in bipolar disorder: a high-intensity follow-up study. J. Affect Disord. 65 (2001), 231–241.
7. Baune, B.T., Malhi, G.S., A review on the impact of cognitive dysfunction on social, occupational and general functional outcomes in bipolar disorder. Bipolar Disord. 17 (2015), 41–55.
8. Bonnín, C.M., Martínez-Arán, A., Torrent, C., et al. Clinical and neurocognitive predictors of functional outcome in bipolar euthymic patients: a long-term, follow-up study. J. Affect Disord. 121 (2010), 156–160.
9. Bonnín, C.M., Torrent, C., Arango, C., et al. Functional remediation in bipolar disorder: 1-year follow-up of neurocognitive and functional outcome. B J. Psych. 208 (2016), 87–93.
10. Bonnín Cdel, M., González-Pinto, A., Solé, B., Reinares, M., González-Ortega, I., Alberich, S., Crespo, J.M., Salamero, M., Vieta, E., Martínez-Arán, A., Torrent, C., CIBERSAM Functional Remediation Group, Verbal memory as a mediator in the relationship between subthreshold depressive symptoms and functional outcome in bipolar disorder. J. Affect Disord. 160 (2014), 50–54.
11. Bora, E., Yucel, M., Pantelis, C., et al. Meta-analytic review of neurocognition in bipolar II disorder. Acta Psychiatr. Scand. 123 (2011), 165–174.
12. Bourne, C., Aydemir, O., Balanza-Martinez, V., et al. Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis. Acta Psychiatr. Scand. 128 (2013), 149–162.
13. Bowie, C.R., Depp, C., McGrath, J.A., et al. Prediction of real-world functional disability In chronic mental disorders: a comparison of schizophrenia and bipolar disorder. Am. J. Psychiatry, 2010, 167–1124.
14. Bryce, S., Sloan, E., Lee, S., et al. Cognitive remediation in schizophrenia: methodological appraisal of systematic reviews and meta-analyses. J. Psychiatr. Res. 75 (2016), 91–106.
15. Burdick, K.E., Goldberg, J.F., Harrow, M., Neurocognitive dysfunction and psychosocial outcome in patients with bipolar I disorder at 15-year follow-up. Acta Psychiatr. Scand. 122:6 (2010), 499–506.
16. Burdick, K.E., Braga, R.J., Nnadi, C.U., et al. Placebo-controlled adjunctive trail of pramipexole in patients with bipolar disorder: targeting cognitive dysfunction. J. Clin. Psychiatry 73 (2012), 103–112.
17. Cardenas, S.A., Kassem, L., Brotman, M.A., et al. Neurocognitive functioning in euthymic patients with bipolar disorder and unaffected relatives: a review of the literature. Neurosci. Biobehav. Rev. 69 (2016), 193–215.
18. Conus, P., Cotton, S., Abdel-Baki, A., et al. Symptomatic and functional outcome 12 months after a first episode of psychotic mania: barriers to recovery in a catchment area sample. Bipolar Disord. 8 (2006), 221–231.
19. Corp, S.A., Gitlin, M.J., Althsuler, L.L., A review of the use of stimulants and stimulant alternatives in treating bipolar depression and major depressive disorder. Am. J. Psychiatry 75 (2014), 1010–1018.
20. Coryell, W., Keller, M., Endicott, J., et al. Bipolar II illness: course and outcome over a five-year period. Psychol. Med. 64 (1989), 1483–1494.
21. Coryell, W., Scheftner, W., Keller, M., et al. The enduring psychosocial consequences of mania and depression. Am. J. Psychiatry 150 (1993), 720–727.
22. Cullen, B., Ward, J., Graham, N.A., et al. Prevalence and correlates of cognitive impairment in euthymic adults with bipolar disorder: a systematic review. J. Affect Disord. 205 (2016), 165–181.
23. Daglas, R., Yucel, M., Cotton, S., et al. Cognitive impairment in first-episode mania: a systematic review of the evidence in the acute and remission phases of the illness. Int. J. Bipolar Disord., 2015, 10.1186/s40345-015-0024-2.
24. Depp, C.A., Mausbach, B.T., Harvey, P.D., et al. Social competence and observer-related social functioning in bipolar disorder. Bipolar Disord. 12 (2010), 843–850.
25. Depp, C.A., Mausbach, B.T., Harmell, A.L., et al. Meta-analysis of the association between cognitive abilities and everyday functioning in bipolar disorder. Bipolar Disord. 14 (2012), 217–226.
26. Dilsaver, S.C., An estimate of the minimum economic burden of bipolar I and II disorders in the United States: 2009. J. Affect Disord. 129 (2011), 79–83.
27. Endicott, J., Spitzer, R.L., Fleiss, J.L., The global assessment scale: a procedure for measuring overall severity of psychiatric disturbance. Arch. Gen. Psychiatry 33 (1976), 766–771.
28. Eysenck, S.B., Eysenck, H.J., An improved short questionnaire for the measurement of extraversion and neuroticism. Life Sci. 3 (1964), 1103–1109.
29. Fan, A.H., Hassell, J., Bipolar disorder and comorbid personality psychopathology: a review of the literature. J. Clin. Psychiatry 69 (2008), 1794–1803.
30. Ferrari, A.J., Stockings, E., Khoo, J.P., Erskine, H.E., Degenhardt, L., Vos, T., Whiteford, H.A., The prevalence and burden of bipolar disorder: findings from the Global Burden of disease study 2013. Bipolar Disord. 18:5 (2016), 440–450.
31. Fett, A.K., Viechtbauer, W., Dominguez, M.D., Penn, D.L., van Os, J., Krabbendam, L., The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis. Neurosci. Biobehav. Rev. 35:3 (2011), 573–588, 10.1016/j.neubiorev.2010.07.001.
32. Frank, E., Soreca, I., Swartz, H.A., et al. The role of interpersonal and social rhythm therapy in improving occupational functioning in in patients with bipolar I disorder. Am. J. Psychiatry 165 (2008), 1559–1565.
33. Frye, MA., et al., Amchin, J., Bauer, M., Randomized, placebo-controlled adjunctive study of armodafinil for bipolar I depression: implications of novel drug design and heterogeneity of concureent bipolar maintenance treatments. Int. J. Bipolar Disord., 1(34), 2015, 10.1186/s40345-015-0034-0.
34. Ghaemi, S.N., Wingo, A.P., Filkowski, M.A., Baldessarini, R.J., Long-term antidepressant treatment in bipolar disorder: meta-analyses of benefits and risks. Acta Psychiatr. Scand. 118 (2008), 347–356.
35. Gignac, A., McGirr, A., Lam, R.W., et al. Recovery and recurrence following a first episode of mania: a systematic review and meta-analysis of prospectively characterized cohorts. J. Clin. Psychiatry 76 (2015), 1241–1248.
36. Gitlin, M., Frye, M.A., Maintenance therapies in bipolar disorders. Bipolar Disord. 14 (2012), 51–65.
37. Gitlin, M.J., Swendsen, J., Heller, T.L., et al. Relapse and impairment in bipolar disorder. Am. J. Psychiatry 152 (1995), 1635–1640.
38. Gitlin, M.J., Mintz, J., Sokolski, K., et al. Subsyndromal depressive symptoms after symptomatic recovery from mania are associated with delayed functional recovery. J. Clin. Psychiatry 72 (2011), 692–697.
39. Goodwin, F.K., Jamison, K.R., Manic-Depressive Illness, 2nd ed, 2007, Oxford University Press, New York, 119–155.
40. Gyulai, L., Bauer, M.S., Marangell, L.B., et al. Correlates of functioning in bipolar disorder. Psychopharmacol. Bull. 41 (2008), 51–64.
41. Hamilton, M., A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23 (1960), 56–62.
42. Hammen, C., Brennan, P.A., Le Brocque, R., Youth depression and early childrearing: stress generation and intergenerational transmission of depression. J. Consult Clin. Psychol. 79 (2011), 353–563.
43. Holmes, M.K., Erickson, K., Luckenbaugh, D.A., et al. A comparison of cognitive functioning in medicated and unmedicated subjects with bipolar depression. Bipolar Disord. 10 (2008), 806–815.
44. Jaeger, J., Berns, S., Loftus, S., et al. Neurocognitive test performance predicts functional recovery from acute exacerbation leading to hospitalization in bipolar disorder. Bipolar Disord. 9 (2007), 93–102.
45. Johnson, S.L., Meyer, B., Winett, C., et al. Social support and self-esteem predict changes in bipolar depression but not mania. J. Affect Disord. 58 (2000), 79–86.
46. Johnson, S.L., Cuellar, A., Ruggero, C., et al. Life events as predictors of mania and depression in bipolar I disorder. J. Abnorm Psychol. 117 (2008), 268–277.
47. Judd, L.L., Akiskal, H.S., Schettler, P.J., et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch. Gen. Psych. 59 (2002), 530–537.
48. Judd, L.L., Akiskal, H.S., Schettler, P.J., et al. A prospective investigation of the natural history investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch. Gen. Psych. 60 (2003), 261–269.
49. Judd, L.L., Akiskal, H.S., Schettler, P.J., et al. Psychosocial disability in course of bipolar I and II disorders: a prospective, comparative, longitudinal study arch. Gen. Psych. 62 (2005), 1322–1330.
50. Judd, L.L., Schettler, P.J., Solomon, D.A., et al. Psychosocial disability and work role function compared across the long-term course of bipolar I, bipolar II and unipolar major depressive disorders. J. Affect Disord. 108 (2008), 49–58.
51. Kahbazi, M., Ghoreishi, A., Rahiminejad, F., et al. A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder. Psychiatry Res. 168 (2009), 234–237.
52. Keck, P.E., Long-term management strategies to achieve optimal function in patients with bipolar disorder. J. Clin. Psychiatry 67 (2006), 19–24.
53. Keck, P.E.J., McElroy, S.L., Strakowski, S.M., et al. Twelve-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. Am. J. Psychiatry 155 (1998), 646–652.
54. Keefe, R.S., Buchanan, R.W., Marder, S.R., et al. Clinical trials of potential cognitive-enhancing drugs in schizophrenia: what have we learned so far?. Schizophr. Bull. 39 (2013), 417–435.
55. Kraepelin, E., Manic Depressive Insanity and Paranoia. 1921, Livingstone, Edinburgh, E.S.
56. Kumar, R., Approved and investigational uses of modafinil. Drugs 68 (2008), 1803–1839.
57. L. O'Donnell D.A. Axelson R.A. Kowatch C. Sugar C.D. Schneck D.J. Miklowitz, 2016. Two-year effects of family-focused treatment on quality of life among adolescents with bipolar disorder. Manuscript Under Review.
58. Lee, R.S., Hermens, D.F., Scott, J., et al. A meta-analysis of neuropsychological functioning in first-episode bipolar disorders. J Psychiatr. Res. 57 (2014), 1–11.
59. Levy, B., Manove, E., Functional outcome in bipolar disorder: the big picture. Depr. Res. Treatm. 949248 (2012), 1–12.
60. Levy, B., Manove, E., Weiss, R.D., Recovery of cognitive functioning in patients with co-occurring bipolar disorder and alcohol dependence during early remission from an acute mood episode. Ann. Clin. Psychiatry 24 (2012), 143–154.
61. Loftus, S.T., Jaeger, J., Psychosocial outcome in bipolar I patients with a personality disorder. J. Nerv. Ment. Dis. 194 (2006), 967–970.
62. MacQueen, G.M., Young, L.T., Joffe, R.T., A review of psychosocial outcome in patients with bipolar disorder. Acta Psychiatr. Scand. 103 (2001), 163–170.
63. Marangell, L.B., Dennehy, E.B., Miyahara, S., et al. The functional impact of subsyndromal depressive symptoms in bipolar disorder: data from STEP-BD. J. Affect Disord. 114 (2009), 58–67.
64. Martino, D.J., Igoa, A., Marengo, E., et al. Neurocognitive impairments and their relationship with psychosocial functioning and euthymic bipolar II disorder. J. Nerv. Ment. Dis. 199 (2001), 459–646.
65. Martino, D.J., Strejilevich, S.A., Marengo, E., et al. Toward the identification of neurocognitive subtypes in euthymic patients with bipolar disorder. J. Affect Disord. 167 (2014), 118–124.
66. Michalak, E.E., Yatham, L.N., Lam, R.W., Quality of life in bipolar disorder: a review of the literature. Health Qual. Life Outcomes, 2005, 10.1186/1477-7525-3-72.
67. Michalak, E.E., Jones, S., Lobban, F., et al. Harnessing the potential of community-based participatory research approaches in bipolar disorder. Int. J. Bipolar Disord., 2016, 10.1186/s40345-016-00485-5.
68. Miklowitz, D.J., Johnson, S.L., Social and familial risk factors in bipolar disorder: basic processes and relevant interventions. Clin. Psychol.: Sci. Pract. 16:2 (2009), 281–296.
69. Miklowitz, D.J., Johnson, S.L., Social and familial factors in the course of bipolar disorder: basic processes and relevant interventions. Clin. Psychol. N.Y. 16 (2009), 281–296.
70. Miklowitz, D.J., Goldstein, M.J., Nuechterlein, K.H., et al. Family factors and the course of bipolar affective disorder. Arch. Gen. Psychiatry 45 (1988), 225–231.
71. Miklowitz, D.J., Otto, M.W., Frank, E., et al. Psychosocial treatments for bipolar depression: a 1-year randomized trial from the systematic treatment enhancement program. Arch. Gen. Psych. 64 (2007), 419–427.
72. Pacchiarotti, I., Bond, D.J., Baldessarini, R.J., et al. The international society of bipolar disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am. J. Psychiatry 167 (2013), 792–800.
73. Pope, M., Dudley, R., Scott, J., Determinant of social functioning in bipolar disorder. Bipolar Disord. 9 (2007), 38–44.
74. Porter, R.J., Robinson, L.J., Malhi, G.S., et al. The neurocognitivie profile of mood disorders – a review of the evidence and methodological issues. Bipolar Disord. 17 (2015), 21–40.
75. Rosa, A.R., Sanchez-Moreno, J., Martinez-Aran, A., et al. Validity and reliability of the functioning assessment short test (FAST) in bipolar disorder. Clin. Pract. Epidemiol. Ment. Health, 2007, 10.1186/1745-0179-3-5.
76. Rosa, A.R., Reinares, M., Amann, B., et al. Six-month functional outcome of a bipolar disorder cohort in context of a specialized-care program. Bipolar Disord. 13 (2011), 679–686.
77. Rosa, A.R.1, Andreazza, A.C., Kunz, M., et al. Validity and reliability of the functioning assessment short test (FAST) in bipolar disorder. Clin. Pract. Epidemiol. Ment. Health 107 (2008), 45–51.
78. Ruggero, C.J., Chelminsky, I., Young, D., et al. Psychosocial impairment associated with bipolar II disorder. J. Affect Disord. 104 (2007), 53–60.
79. Ruth, A.J., Gullion, C.M., Basco, M.R., et al. The inventory of depressive symptomatology (IDS): psychometric properties. Psychol. Med. 26 (1996), 477–486.
80. Salcedo, S., Gold, A.K., Sheikh, S., Marcus, P.H., Nierenberg, A.A., Deckersbach, T., Sylvia, L.G., Empirically supported psychosocial interventions for bipolar disorder: current state of the research. J. Affect. Disord. 201 (2016), 203–214.
81. Samaline, L., de Chazeron, I., Vieta, E., et al. Residual symptoms and specific functional impairments in euthymic patients with bipolar disorder. Bipolar Disord. 18 (2016), 164–173.
82. Samamé, C., Martino, D.J., Strejilevich, S.A., Longitudinal course of cognitive deficits in bipolar disorder: a meta analytic study. J. Affect Disord. 164 (2014), 130–138.
83. Sanchez-Moreno, J., Martinez-Aran, A., Tabarés-Seisdedos, R., et al. Functioning and disability in bipolar disorder: an extensive review. Psychother. Psychosom. 78 (2009), 285–297.
84. Scott, J., Psychotherapy for bipolar disorders: efficacy and effectiveness. J. Psychopharmacol. 20 (2006), 46–50.
85. Sidor, M.M., MacQueen, G.M., An update on antidepressant use in bipolar depression. Curr. Psychiatry Rep. 14 (2012), 696–704.
86. Simon, G.E., Bauer, M.S., Ludman, E.J., et al. Mood Symptoms, functional impairment, and disability in people with bipolar disorder: specific effects of mania and depression. J. Clin. Psychiatry 68 (2007), 1237–1245.
87. Sole, B., Bonnin, C.M., Torrent, C., et al. Neurocognitive impairment and psychosocial functioning in bipolar disorder. Acta Psychiatr. Scand. 125 (2012), 309–371.
88. Sole, B., Bonnin, C.M., Mayoral, M., et al. Functional remediation for patients with bipolar II disorder: improvement of functioning and subsyndromal symptoms. Eur. Neuropsychopharmacol. 25 (2015), 257–264.
89. Strejilevich, S.A., Martino, D.J., Murru, A., et al. Mood instability and functional recovery in bipolar disorder. Acta Psychiatr. Scand. 128 (2013), 194–202.
90. Strejilevich, S.A., Samame, C., Martino, D.J., The trajectory of neuropsychological dysfunctions in bipolar disorders: a critical examination of hypothesis. J. Affect Disord. 175 (2015), 396–402.
91. Swartz, H.A., Pilkonis, P.A., Frank, E., et al. Acute treatment outcomes in patients with bipolar I disorder and co-morbid borderline personality disorder receiving medication and psychotherapy. Bipolar Disord. 7 (2005), 192–197.
92. Tabarés-Seisdedos, R., Balanzá-Martínez, V., Sánchez-Moreno, J., et al. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow up. J. Affect Disord. 109 (2008), 286–299.
93. Tohen, M., Hennen, J., Zarate, C.M. Jr, et al. Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am. J. Psychiatry 157 (2000), 220–228.
94. Torrent, C., Martinez-Arán, A., del Mar Bonnin, C., Reinares, M., Daban, C., Solé, B., Rosa, A.R., Tabarés-Seisdedos, R., Popovic, D., Salamero, M., Vieta, E., Long-term outcome of cognitive impairment in bipolar disorder. J. Clin. Psychiatry 73 (2012), e899–e905.
95. Torrent, C., Bonnin, C.M., Anabel, Martinez-Aran, et al. Efficacy of functional remediation in bipolar disorder: a multicenter randomized controlled study. Am. J. Psychiatry 170 (2013), 852–859.
96. Tse, S., Chan, S., Ng, K.L., et al. Meta-analysis of predictors of favorable employment outcomes among individuals with bipolar disorder. Bipolar Disord. 16 (2014), 217–229.
97. Vázquez, G.H., Tondo, L., Undurraga, J., Baldessarini, R.J., Overview of antidepressant treatment of bipolar depression. Int. J. Neuropsychopharmacol. 16 (2013), 1673–1685.
98. Weinstock, L.M., Miller, I.W., Functional impairment as a predictor of short-term symptom course in bipolar I disorder. Bipolar Disord. 10 (2008), 437–442.
99. Weiss, R.D., Griffin, M.L., Jaffee, et al. A community-friendly” version of integrated group therapy for patients with bipolar disorder and substance dependence: a randomized controlled trial. Drug Alcohol Depend. 104 (2009), 212–219.
100. Wingo, A.P., Harvey, P.D., Baldessarini, R.J., et al. Neurocognitive impairment in bipolar disorder patients: functional implications. Bipolar Disord. 11:2 (2009), 113–125.
101. Young, R.C., Biggs, J.T., Ziegler, V.E., et al. A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry 133 (1978), 429–435.
102. Zyko, S., Jabben, N., Schulte, P., et al. A pilot study of combined group and individual functional remediation program for patients with bipolar I disorder. J. Affect Disord. 194 (2016), 9–15.